Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | GCGR | P47871 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25672847 | 0.98 | ALDH1A1 (0.62) | ALDH1A1MAPK1PTGS2PTGS1CYP1A2 | |
| SCHEMBL30758907 | 0.91 | ALDH1A1 (0.54) | ALDH1A1MAPK1PTGS2PTGS1CYP1A2 | |
| SCHEMBL12489603 | 0.87 | ALDH1A1 (0.83) | ALDH1A1MAPK1TSHRHPGDTDP1 | |
| SCHEMBL23533675 | 0.84 | MAPK1 (0.52) | ALDH1A1MAPK1PTGS2PTGS1CYP1A2 | |
| SCHEMBL9862848 | 0.82 | CYP1A2 (0.63) | ALDH1A1PTGS2PTGS1CYP1A2TSHR | |
| SCHEMBL673353 | 0.80 | MAPK1 (0.71) | ALDH1A1MAPK1TSHRHPGDSLC6A3 | |
| SCHEMBL3778039 | 0.80 | ALDH1A1 (0.90) | ALDH1A1MAPK1PTGS2CYP1A2TSHR | |
| SCHEMBL30121160 | 0.80 | ALDH1A1 (0.90) | ALDH1A1MAPK1PTGS2CYP1A2TSHR | |
| SCHEMBL30523573 | 0.80 | ALDH1A1 (0.52) | ALDH1A1MAPK1PTGS2PTGS1CYP1A2 | |
| SCHEMBL18133372 | 0.80 | CYP2A6 (0.52) | ALDH1A1MAPK1PTGS2PTGS1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119361834-A | Electrolyte and battery and electricity utilization device containing same | 浙江大学 | 2025-01-24 | — | — | CN | claimed |
| CN-114230433-B | Synthesis method of 2-bromo-4 '-chloro-1, 1' -biphenyl | 郑州海阔光电材料有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116768785-A | Synthesis method of spirofluorene-containing indole derivative structure | 西安欧得光电材料有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-114230433-A | Synthetic method of 2-bromo-4 '-chloro-1, 1' -biphenyl | 郑州海阔光电材料有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-122094955-A | Compound, light-emitting device, display device, electronic apparatus, and lighting device | — | 2026-05-26 | — | — | CN | disclosed |
| US-12630496-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260092057-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12552809-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2026-02-17 | — | — | US | disclosed |
| US-20260035339-A1 | TETRAHYDRONAPHTHALENE DERIVATIVE | ATRANSEN PHARMA LTD (JP) | 2026-02-05 | — | — | US | disclosed |
| US-20260040760-A1 | Hole-Transport Layer Material, Electron-Blocking Layer Material, Electron-Transport Layer Material, Hole-Blocking Layer Material, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, And Lighting Device | SEMICONDUCTOR ENERGY LAB (JP) | 2026-02-05 | — | — | US | disclosed |
| US-12527215-B2 | Compound for organic electrical element, organic electrical element using same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2026-01-13 | — | — | US | disclosed |
| US-20250359423-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2025-11-20 | — | — | US | disclosed |
| WO-2005049593-A2 | N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS | ABBOTT LABORATORIES (US) | 2005-06-02 | — | — | WO | disclosed |
| US-20040158074-A1 | Substituted biphenyl compounds for the treatment of inflammation | G.D. SEARLE & CO. | 2004-08-12 | — | — | US | disclosed |
| US-6677488-B2 | AS AN EXAMPLE, 4-(4,5-DIFLUORO-2-(3-CHLORO-4-FLUOROPHENYL) PHENYLBENZENESULFONAMIDE; ANTIARTHRITIC AGENTS; ANTIPYRETICS; ANALGESICS; PROSTAGLANDIN INHIBITORS; SIDE EFFECT REDUCTION | G.D. SEARLE & CO. | 2004-01-13 | — | — | US | disclosed |
| US-20020169206-A1 | Substituted biphenyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2002-11-14 | — | — | US | disclosed |
| EP-0794942-B1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-05-31 | — | — | EP | disclosed |
| US-5739166-A | ALKYLSULFONYL OR AMINOSULFONYL SUBSTITUTED AROMATIC COMPOUNDS AS NON-STEROIDAL ANTIINFLAMMATORY AGENT | G.D. SEARLE & CO. (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0794942-A1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996016934-A1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169206-A1 | Substituted biphenyl compounds for the treatment of inflammation | AHR, ARNT, GPBAR1 | ALDH1A1 241/4885MAPK1 1864/4885PTGS2 379/4885 |
| US-20260040760-A1 | Hole-Transport Layer Material, Electron-Blocking Layer Material, Electron-Transport Layer Material, Hole-Blocking Layer Material, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, And Lighting Device | CTNNB1, AXIN2, SLC9A2 | ALDH1A1 2982/4885MAPK1 1033/4885PTGS2 3393/4885 |
| US-20040158074-A1 | Substituted biphenyl compounds for the treatment of inflammation | AHR, ARNT, GPBAR1 | ALDH1A1 241/4885MAPK1 1864/4885PTGS2 379/4885 |
| US-20260092057-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | BCL2L2, BCL2A1, BCL2L1 | ALDH1A1 1304/4885MAPK1 2564/4885PTGS2 178/4885 |
| US-20250359423-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS THEREOF | PIEZO1, SLCO4C1, POU2F1 | ALDH1A1 580/4885MAPK1 1346/4885PTGS2 2823/4885 |
| US-20260035339-A1 | TETRAHYDRONAPHTHALENE DERIVATIVE | LATS1, LATS2, BCAT1 | ALDH1A1 1267/4885MAPK1 152/4885PTGS2 3642/4885 |
| US-12552809-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | KCNE1, KCNN4, RER1 | ALDH1A1 1374/4885MAPK1 659/4885PTGS2 3341/4885 |
| US-12630496-B2 | Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device | CRY1, NR1I2, GNA11 | ALDH1A1 66/4885MAPK1 1472/4885PTGS2 2858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.